MEDICO REMEDIES
|
MEDICO REMEDIES Last 5 Year Financial Ratios History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 1.00 | 0.87 | 2.90 | 6.24 | 3.93 |
| CEPS(Rs) | 1.35 | 1.20 | 0.85 | 0.51 | 0.40 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 6.31 | 5.28 | 22.04 | 78.22 | 71.98 |
| Tax Rate(%) | 26.86 | 28.29 | 25.78 | 30.00 | 26.40 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 8.91 | 6.75 | 6.06 | 4.28 | 3.21 |
| EBIT Margin(%) | 8.39 | 7.72 | 5.90 | 3.77 | 3.69 |
| Pre Tax Margin(%) | 7.82 | 7.19 | 5.36 | 3.02 | 2.50 |
| PAT Margin (%) | 5.72 | 5.16 | 3.98 | 2.12 | 1.84 |
| Cash Profit Margin (%) | 7.71 | 7.09 | 5.81 | 3.46 | 3.72 |
| Performance Ratios | |||||
| ROA(%) | 8.85 | 8.63 | 6.24 | 3.43 | 2.15 |
| ROE(%) | 17.23 | 18.01 | 13.94 | 8.31 | 5.61 |
| ROCE(%) | 21.90 | 21.88 | 15.09 | 10.13 | 7.66 |
| Asset Turnover(x) | 1.55 | 1.67 | 1.57 | 1.62 | 1.17 |
| Sales/Fixed Asset(x) | 3.62 | 3.95 | 3.95 | 4.60 | 3.79 |
| Working Capital/Sales(x) | 4.65 | 6.10 | 6.23 | 5.96 | 5.48 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.28 | 0.25 | 0.25 | 0.22 | 0.26 |
| Receivable days | 107.96 | 86.40 | 87.18 | 76.51 | 109.06 |
| Inventory Days | 45.38 | 49.13 | 49.25 | 48.92 | 70.69 |
| Payable days | 119.19 | 120.01 | 135.32 | 119.00 | 187.40 |
| Valuation Parameters | |||||
| PER(x) | 49.32 | 85.61 | 5.79 | 0.80 | 0.93 |
| PCE(x) | 36.61 | 62.23 | 19.83 | 9.79 | 9.23 |
| Price/Book(x) | 7.81 | 14.14 | 3.81 | 1.28 | 1.02 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 2.87 | 4.47 | 1.22 | 0.44 | 0.48 |
| EV/Core EBITDA(x) | 27.63 | 46.22 | 15.77 | 8.57 | 8.68 |
| EV/EBIT(x) | 34.18 | 57.82 | 20.67 | 11.63 | 13.09 |
| EV/CE(x) | 7.03 | 12.07 | 1.88 | 0.71 | 0.57 |
| M Cap / Sales | 2.82 | 4.41 | 1.15 | 0.34 | 0.34 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 3.19 | 16.04 | -1.12 | 38.08 | -9.27 |
| Core EBITDA Growth(%) | 10.85 | 44.89 | 49.34 | 26.98 | 5.85 |
| EBIT Growth(%) | 12.10 | 51.79 | 54.66 | 41.11 | 3.85 |
| PAT Growth(%) | 14.49 | 50.49 | 85.79 | 58.86 | 3.84 |
| EPS Growth(%) | 14.50 | -69.90 | -53.54 | 58.83 | 3.84 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.13 | 0.18 | 0.29 | 0.46 | 0.46 |
| Current Ratio(x) | 1.70 | 1.53 | 1.49 | 1.54 | 1.40 |
| Quick Ratio(x) | 1.33 | 1.08 | 1.03 | 1.16 | 0.95 |
| Interest Cover(x) | 14.76 | 14.52 | 10.79 | 5.02 | 3.09 |
| Total Debt/Mcap(x) | 0.02 | 0.01 | 0.08 | 0.36 | 0.46 |
Compare Financial Ratios of peers of MEDICO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICO REMEDIES | ₹370.9 Cr | -21.1% | -11.2% | -41.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,518.0 Cr | -0.1% | -6.3% | 49.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,636.0 Cr | 3.5% | 0.9% | 66.2% | Stock Analytics | |
| CIPLA | ₹118,368.0 Cr | -2.6% | -3.8% | 19.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,671.4 Cr | -4.1% | -10.8% | 9.5% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹95,013.6 Cr | -2% | -6.1% | 49.9% | Stock Analytics | |
MEDICO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICO REMEDIES | -21.1% |
-11.2% |
-41.5% |
| SENSEX | -1.9% |
-5% |
17.5% |
You may also like the below Video Courses
